Pfizer says its Covid vaccine candidate 95% effective with no major side-effects
New York: Pfizer and its German partner BioNTech released a second batch of interim results on Wednesday, saying their two-dose coronavirus vaccine candidate is 95 per cent effective and also protects the most vulnerable people in older age…